Risk Factors and Rates of Fungal Infection in Lung Transplant Recipients Who Receive Posaconazole and Inhaled Amphotericin Combination Prophylaxis Therapy.

A.A. Perez, J.P. Singer, D. Calabrese, A. Venado, J. Greenland, L.E. Leard, R.J. Shah, N.A. Kolaitis, J.A. Golden, M. Kleinhenz, J. Kukreja, B. Trinh, S.R. Hays. Risk Factors and Rates of Fungal Infection in Lung Transplant Recipients Who Receive Posaconazole and Inhaled Amphotericin Combination Prophylaxis Therapy. The Journal of Heart and Lung Transplantation. 2021 Apr 1; 40(4):s343.

2021
https://researcherprofiles.org/profile/192871147

A.A. Perez, J.P. Singer, D. Calabrese, A. Venado, J. Greenland, L.E. Leard, R.J. Shah, N.A. Kolaitis, J.A. Golden, M. Kleinhenz, J. Kukreja, B. Trinh, S.R. Hays